Posted On: September 26, 2008

Carey & Danis Announces Auction Rate Securities Class Action Lawsuit Filed Against H&R Block

FOR IMMEDIATE RELEASE
FRIDAY, SEPT. 26, 2008
CONTACT: JOSEPH P. DANIS
MICHAEL J. FLANNERY
COREY D. SULLIVAN
Phone: 1-800-721-2519

NEWS RELEASE

Sept. 26, 2008

Carey & Danis LLC Announces Auction Rate Securities Class Action Lawsuit Filed Against H&R Block (NYSE: HRB).

St. Louis, MO – The law firm of Carey & Danis LLC (www.careydanis.com) has filed a class action lawsuit on behalf of persons who purchased auction rate securities from H&R Block, Inc. (NYSE: BAC), and H&R Block Financial Advisors, Inc., between Aug. 26, 2003 and Feb. 13, 2008 and who continued to hold the securities as of Feb. 13, 2008.

The class action lawsuit, La Grave v. H&R Block, Inc., et al., 08-cv-667, is pending in the U.S. District Court for the Southern District of Illinois. The suit alleges that H&R Block, Inc. and its subsidiary H&R Block Financial Advisors, Inc., violated Sections 10(b) and 20(a) of the Securities Exchange Act of 1934 by deceiving investors about the investment characteristics of auction rate securities and the auction market in which the securities are traded.

Continue reading " Carey & Danis Announces Auction Rate Securities Class Action Lawsuit Filed Against H&R Block " »

Posted On: September 9, 2008

Heparin’s Safety is Flagged by the FDA

The Food and Drug Administration recently identified the blood-thinning drug heparin as one of 20 medications with potential safety issues.

According to a statement released last Friday, the FDA noted that in the first three months of 2008, heparin was associated with anaphylactic-type reactions. Anaphylaxis is a severe, whole-body allergic reaction that can be fatal. Symptoms range from nausea and diarrhea to shortness of breath and dangerously low blood pressure. By June, 149 deaths in the U.S. had been linked to heparin.

Continue reading " Heparin’s Safety is Flagged by the FDA " »